This indicated that staurosporine can decrease the invasive capability of cancer cells through the inhibition of MMP-9 and uPA protein levels in lung cancer cells and is consistent with other reports [20-22] We understand the importance of interpreting these results in the light of the increased apoptosis observed in staurosporine treated cells and the resulting loss in cell viability. This evidence concerns the gene MMP9 and lung cancer.